GSK 366
Modify Date: 2025-11-27 06:17:54
GSK 366 structure
|
Common Name | GSK 366 | ||
|---|---|---|---|---|
| CAS Number | 1953157-39-5 | Molecular Weight | 361.78 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H16ClN3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK 366GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively [1]. |
| Name | GSK 366 |
|---|
| Description | GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively [1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.3 nM (human KMO), 0.7 nM (Pf-KMO)[1] |
| References |
| Molecular Formula | C17H16ClN3O4 |
|---|---|
| Molecular Weight | 361.78 |
| InChIKey | YWASLAPMFGBZQP-SNVBAGLBSA-N |
| SMILES | Cc1ccc(C(C)Oc2cc3onc(CCC(=O)O)c3cc2Cl)nn1 |